Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & PerspectivesShorts
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Stephen G. Weiss II, MD, FACS

Advertisement

Articles by Stephen G. Weiss II, MD, FACS

Urologist to ABU: ‘I relinquish my certificate’ over MOC (Letter)

ByStephen G. Weiss II, MD, FACS
July 1st 2015

Urologist Stephen G. Weiss II, MD, FACS, explains why he is voluntarily relinquishing his American Board of Urology certificate.

Advertisement

Latest Updated Articles

  • Urologist to ABU: ‘I relinquish my certificate’ over MOC (Letter)
    Urologist to ABU: ‘I relinquish my certificate’ over MOC (Letter)

    July 1st 2015



Advertisement
Advertisement

Trending on Urology Times

1

FDA approves Titan Prime Inflatable Penile Prosthesis

2

Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026

3

RAD-IO: Durvalumab plus chemoradiotherapy is feasible in MIBC

4

Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617

5

The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us